Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check7 days agoChange DetectedOnly minor formatting/text updates observed; no changes to inclusion criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check14 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check21 days agoChange DetectedPublications section now notes that items are auto-filled from PubMed and shows revision v3.3.1, replacing the previous PubMed-specific wording and the v3.2.0 label. To avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check29 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page. Previously, it informed users about potential delays and updates on government operations.SummaryDifference0.3%
- Check36 days agoChange DetectedNo substantive changes were detected in the Study Details page between the two screenshots. Core content such as inclusion criteria, interventions, primary outcomes, and location listings appears unchanged.SummaryDifference0.1%
- Check43 days agoChange DetectedNo substantive changes detected between the two screenshots. The page content and structure appear unchanged.SummaryDifference0.3%
Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.